The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection ...

For the millions of Americans affected by Alzheimer's. The road to battling the disease has been bumpy but an experimental medication is offering new hope. It's not *** cure. It is not going to be ...

To qualify for drug treatment, Alzheimer’s patients now generally get a specialized PET scan to detect amyloid in their brains or undergo a cerebrospinal fluid test. The PET scans are expensive ...